The effectiveness of endoscopic sclerotherapy in the treatment of esophageal varices in children with prehepatic portal hypertension
Topic overview
This retrospective study evaluates endoscopic sclerotherapy outcomes in 64 pediatric patients with esophageal varices from extrahepatic portal hypertension over 32 years. Success rates improved significantly to 88% in the most recent decade, demonstrating EST as an effective minimally invasive treatment option for children with portal vein thrombosis.
Key takeaways
- Endoscopic sclerotherapy achieved 68.8% success in controlling esophageal varices from extrahepatic portal hypertension in children.
- Success rates improved significantly over time: 60% (1990-2000) to 88.2% (2011-2022) with advancing technology and experience.
- Average 4.1 sclerotherapy sessions needed to achieve variceal control without transfusion-requiring bleeding for one year.
- One-third of patients required surgical intervention due to advanced varices, frequent bleeding, or treatment failure.
- EST is safe first-line therapy for F2+ esophageal varices in pediatric EHPH before considering surgical shunt procedures.
Keywords
Hashtags
Full article text
Full article text not available for this entry
How to cite: GlobalCastMD. The effectiveness of endoscopic sclerotherapy in the treatment of esophageal varices in children with prehepatic portal hypertension. GlobalCastMD Medical Library. 2024-12-20. https://dev.library.globalcastmd.com/article/9553?via_space=staycurrentmd
Comments